Mark Cherney is the Founder and Executive Chairman of both US Urology Partners and Prologics. This past year Mark transitioned from the CEO role into the Executive Chair role and in this brief discussion he introduces some of the headwinds ahead for both Private Equity & the medical practices that have been part of PE roll-ups.
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...
Kerry Curran brings a career in medical device technology to a nimble startup leveraging student engineering skill to design products addressing post surgical Pulmonary...
